Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (101-110 of 438) with videos related to

Pageof 44
Sort By:
Cancer Treatment Reviews|April 25, 2022
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectivesEleonora Nicolò, Federica Giugliano, Liliana Ascione, et al.
Oncology (Williston Park, N.Y.)|April 18, 2016
Is Personalized Medicine Here?Benedito A Carneiro, Ricardo Costa, Timothy Taxter, et al.
Current Problems in Diagnostic Radiology|April 25, 2018
Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast CancerBasak E Dogan, Qing Yuan, Roland Bassett, et al.
Cancer|May 17, 2002
Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinomaEdgardo Rivera, Vicente Valero, Massimo Cristofanilli, et al.
The Journal of Surgical Research|June 2, 2009
A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancerEugene H Huang, Balraj Singh, Massimo Cristofanilli, et al.
Clinical Breast Cancer|January 24, 2007
Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinomaAna Maria Gonzalez-Angulo, Aysegul Sahin, Savitry Krishnamurthy, et al.
Breast Cancer Research and Treatment|July 9, 2017
Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancerZhaomei Mu, Chun Wang, Zhong Ye, et al.
Clinical & Experimental Metastasis|March 16, 2010
Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancerBalraj Singh, Kendra R Cook, Cecilia Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Prognostic value of body mass index in locally advanced breast cancerShaheenah Dawood, Kristine Broglio, Ana M Gonzalez-Angulo, et al.
Journal of Cancer|May 7, 2014
Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cellsWendy A Woodward, Savitri Krishnamurthy, Ashutosh Lodhi, et al.
Pageof 44

Showing results (101-110 of 438) with videos related to

Sort By:
Pageof 44
Cancer Treatment Reviews|April 25, 2022
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectivesEleonora Nicolò, Federica Giugliano, Liliana Ascione, et al.
Oncology (Williston Park, N.Y.)|April 18, 2016
Is Personalized Medicine Here?Benedito A Carneiro, Ricardo Costa, Timothy Taxter, et al.
Current Problems in Diagnostic Radiology|April 25, 2018
Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast CancerBasak E Dogan, Qing Yuan, Roland Bassett, et al.
Cancer|May 17, 2002
Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinomaEdgardo Rivera, Vicente Valero, Massimo Cristofanilli, et al.
The Journal of Surgical Research|June 2, 2009
A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancerEugene H Huang, Balraj Singh, Massimo Cristofanilli, et al.
Clinical Breast Cancer|January 24, 2007
Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinomaAna Maria Gonzalez-Angulo, Aysegul Sahin, Savitry Krishnamurthy, et al.
Breast Cancer Research and Treatment|July 9, 2017
Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancerZhaomei Mu, Chun Wang, Zhong Ye, et al.
Clinical & Experimental Metastasis|March 16, 2010
Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancerBalraj Singh, Kendra R Cook, Cecilia Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Prognostic value of body mass index in locally advanced breast cancerShaheenah Dawood, Kristine Broglio, Ana M Gonzalez-Angulo, et al.
Journal of Cancer|May 7, 2014
Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cellsWendy A Woodward, Savitri Krishnamurthy, Ashutosh Lodhi, et al.
Pageof 44